Analyst Ratings for Cohen & Steers Inc. (CNS)Updated: 2017-07-27
Shares of Cohen & Steers Inc. (NYSE:CNS) have received a consensus rating of Overweight from Wall Street analysts. A consensus rating of Overweight was previously issued for CNS last month.
3 analysts declared CNS a buy, 0 gave an overweight rating, 3 gave a hold rating, 1 issued an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
Many analysts weighed in on price targets for CNS. The most optimistic analyst gave a price target of 46, implying potential capital gains of 10.84 percent. The most pessimistic price target was 35, implying potential capital losses of -15.66 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
Analysts have revised their earnings estimates upwards for this quarter, by about 4.04 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is 4.04 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 2.82 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 2.82 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. Over the same time period, 3 analysts revised their FY earnings estimates upwards, while 0 analysts made negative revisions to their fiscal year's estimates.
Analysts estimate earnings of CNS to grow at a rate of -3.87 percent. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. People often look for the PEG ratio to be under 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of CNS is -5.2.
In the trailing 52-weeks, CNS hit 43.54 at the highest peak, while it's lowest trading point was 33.16. Today's price is 25.15 percent above the 52-week low, and below the high by 4.69 percent. CNS has a P/E ratio of 20.13. Investors typically compare the P/E ratio to a company's peers in the industry. The CNS value stock report compares CNS to some of its peers using value stock charts. The market cap of CNS is $1.94 billion. CNS is estimated to release their earnings results for the quarter on 0000-00-00, days from today.